SHERIDAN, WYOMING – May 6, 2025 – BD (Becton, Dickinson and Company), a global leader in medical technology, has announced the induction of Eric Diebold, Ph.D., Vice President and General Manager of Instruments, Software, and Informatics, Biosciences, to the prestigious American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
SHERIDAN, WYOMING – May 6, 2025 – BD (Becton, Dickinson and Company), a global leader in medical technology, has announced its participation in the upcoming Bank of America Securities Health Care Conference, scheduled for Tuesday, May 13, 2025, at 1:00 pm Eastern Time. The live webcast of the presentation will be available on the BD investor relations website, with a replay accessible afterward for those unable to attend the live event.
SHERIDAN, WYOMING – May 5, 2025 – International healthcare leader Bupa has unveiled pivotal insights from its whole genome sequencing initiative, ‘My Genomic Health’, revealing significant hidden health risks in the majority of participants and marking a transformative step in the future of preventive healthcare. Designed to provide personalised, actionable data, the programme is reshaping how genetic information is used to drive early intervention and long-term wellness outcomes in the UK, Spain, and beyond.